Affiliation:
1. Samara State Medical University
Abstract
Introduction. A large increase in the incidence of catarrhal rhinosinusitis determines the search for new methods of treating these patients. In this regard, the use of herbal preparations for relieving the symptoms of this nosology is of increasing interest. The article discusses the problems of using drugs based on Cyclamen europaeum (CE ) in the treatment of acute catarrhal rhinosinusitis.Purpose of the study. Evaluation of the effectiveness of CE extract in the complex treatment of acute catarrhal rhinosinusitis.Materials and methods. A randomized controlled study was carried out to study the efficacy of cyclamen europaeum extract in outpatients with an established diagnosis of acute catarrhal rhinosinusitis (the presence of 2 or more symptoms of acute rhinosinusitis, the presence of radiological signs of acute catarrhal rhinosinusitis.Results. The results of the study showed that the intranasal use of drugs based on CE in acute catarrhal rhinosinusitis helps to reduce headache, reduces the abundance of nasal discharge, promotes the early restoration of nasal breathing, as well as smell and taste.Discussion. The study objectively confirmed that the use of drugs based on CE has a positive effect on the dynamics of the course of acute catarrhal rhinosinusitis, promotes the early restoration of the epithelium of the nasal mucosa, olfactory function, and also has a positive effect on the restoration of gustatory function.Conclusions. Based on the results of this study, it can be concluded that it is advisable to use drugs based on CE in the treatment of acute catarrhal rhinosinusitis.
Reference31 articles.
1. Asmanov A.I., Pivneva N.D. Acute sinusitis: modern approaches to diagnosis and treatment. Paediatrician Practice. 2016;(4):28–37. (In Russ.) Available at: https://medi.ru/pp/arhiv/2016/sentyabr_2016/4244/.
2. Fokkens W.J., Lund V.J., Hopkins C., Hellings P.W., Kern R., Reitsma S. et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2020. Rhinology. 2020;58(S29 Suppl.):1–464. https://doi.org/10.4193/Rhin20.600.
3. Hoffmans R., Wagemakers A., van Drunen C., Hellings P., Fokkens W. Acute and chronic rhinosinusitis and allergic rhinitis in relation to comorbidity, ethnicity and environment. PLoS ONE. 2018;13(2):e0192330. https://doi. org/10.1371/journal.pone.0192330.
4. Fokkens W., Lund V., Mullol J. European position paper on rhinosinusitis and nasal polyps 2007. Rhinol Suppl. 2007;20:1–136. Available at: https://pubmed.ncbi.nlm.nih.gov/17844873.
5. Fokkens W.J., Lund V.J., Mullol J., Bachert C., Alobid I., Baroody F. et al. EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists. Rhinology. 2012;50(1):1–12. https://doi.org/10.4193/Rhino12.000.